PODNL1 and cancer: Further analyses indicated that PODNL1 was expressed in different cancer cell lines in CCLE datasets, and higher in fibroblasts and brain tumor cells (Figure 2B), and its expression was enhanced in cell lines of fHDF/TERT166, HSkMC, hTERT-RPE1, SiHa and U-2-OS, which were derived from brain, muscle, female reproductive system, and mesenchymal tissues, respectively, in HPA datasets (Figure 2C).